Live birth rates in the different combinations of the Bologna criteria poor ovarian responders: a validation study-Reference-Cited by-同舟云学术

Live birth rates in the different combinations of the Bologna criteria poor ovarian responders: a validation study

Published:2015-05-01 Issue:6 Volume:32 Page:931-937
ISSN:1058-0468
Container-title:Journal of Assisted Reproduction and Genetics
language:en
Short-container-title:J Assist Reprod Genet

Author:

La Marca Antonio,Grisendi Valentina,Giulini Simone,Sighinolfi Giovanna,Tirelli Alessandra,Argento Cindy,Re Claudia,Tagliasacchi Daniela,Marsella Tiziana,Sunkara Sesh Kamal

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Developmental Biology,Obstetrics and Gynecology,Genetics,Reproductive Medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10815-015-0476-4.pdf

Reference44 articles.

1. La Marca A, Sunkara SK. Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice. Hum Reprod Update. 2014;20(1):124–40.

2. Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L. ESHRE working group on POR definition. Hum Reprod. 2011;26(7):1616–24.

3. La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio AC, et al. Anti-mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update. 2010;16(2):113–30.

4. La Marca A, Grisendi V, Giulini S, Argento C, Tirelli A, Dondi G, et al. Individualization of the FSH starting dose in IVF/ICSI cycles using the antral follicle count. J Ovarian Res. 2013;6(1):11.

5. La Marca A, Dondi G, Sighinolfi G, Giulini S, Papaleo E, Cagnacci A, et al. The ovarian response to controlled stimulation in IVF cycles may be predictive of the age at menopause. Hum Reprod. 2014;29(11):2530–5.

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of breast cancer prognostic factors on ovarian reserve and response in fertility preservation;Reproductive BioMedicine Online;2024-11

2. Development and validation of a prediction model for suboptimal ovarian response in polycystic ovary syndrome (PCOS) patients undergoing GnRH-antagonist protocol in IVF/ICSI cycles;Journal of Ovarian Research;2024-05-28

3. Development and validation of a prediction model for unexpected poor ovarian response during IVF/ICSI;Frontiers in Endocrinology;2024-03-04

4. Ultra-low–dose and very-low–dose Lupron downregulation protocols for poor responders based on POSEIDON group 3 and 4 classifications;Journal of Assisted Reproduction and Genetics;2023-06-16

5. Use of a recombinant human follicle-stimulating hormone:recombinant human luteinizing hormone (r-hFSH:r-hLH) 2:1 combination for controlled ovarian stimulation during assisted reproductive technology treatment: A real-world study of routine practice in the Russian Federation;Best Practice & Research Clinical Obstetrics & Gynaecology;2022-12